As of Sep 25
| -0.01 / -1.94%|
The 1 analysts offering 12-month price forecasts for Rxi Pharmaceuticals Corp have a median target of 6.50, with a high estimate of 6.50 and a low estimate of 6.50. The median estimate represents a +1,187.13% increase from the last price of 0.51.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.